Documents
Application Sponsors
ANDA 212469 | PADAGIS ISRAEL | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | SPRAY;NASAL | 2.5MG/SPRAY | 0 | ZOLMITRIPTAN | ZOLMITRIPTAN |
002 | SPRAY;NASAL | 5MG/SPRAY | 0 | ZOLMITRIPTAN | ZOLMITRIPTAN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-09-30 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
PADAGIS ISRAEL
cder:Array
(
[0] => Array
(
[ApplNo] => 212469
[companyName] => PADAGIS ISRAEL
[docInserts] => ["",""]
[products] => [{"drugName":"ZOLMITRIPTAN","activeIngredients":"ZOLMITRIPTAN","strength":"2.5MG\/SPRAY","dosageForm":"SPRAY;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ZOLMITRIPTAN","activeIngredients":"ZOLMITRIPTAN","strength":"5MG\/SPRAY","dosageForm":"SPRAY;NASAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/30\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-09-30
)
)